3655 results for «215»
3655 results
Maintaining selective coronary access after TAVI and re-do TAVI procedures
28 Nov 2022 – From PCR London Valves 2022
Watch this session if you want to understand the various challenges when trying to get coronary access after TAVI, learn different techniques and discuss the options for coronary access after re-do TAVI.
Optimising immediate and long-term outcomes after TAVI
29 Nov 2022 – From PCR London Valves 2022
This session addresses three important topics that impact post-procedural and long-term outcomes after performing TAVI: the impact of permanent pacemaker rates and paravalvular leak, the importance of neo-commissural alignment, and the role of cerebral embolic protection.
The right valves for the right ventricle: Venus MedTech tricuspid and pulmonary replacement systems
27 Nov 2022 – From PCR London Valves 2022
In this session from PCR London Valves 2022, discover the new Venus MedTech technology for tricuspid and pulmonary valve replacement, and a review of the clinical indications, selection criteria and procedural details.
Therapy of valvular heart diseases: a patient-centred innovation journey
27 Nov 2022 – From PCR London Valves 2022
Join a team of experts as they review together the complete spectrum of valvular heart disease and ways in which we can manage it using emerging novel technologies.
Tricuspid valve interventions in heart failure patients - Treatment optimisation and pre-procedural work-up
27 Nov 2022 – From PCR London Valves 2022
Consult these presentations to learn more about tricuspid valve intervention in heart failure patients, to discover which patients are suitable candidates for this procedure and to appreciate the importance of imaging, haemodynamic assessment, optimised medical and heart rhythm treatment prior to this intervention.
Reinventing the treatment of patients with tricuspid valve disease
28 Nov 2022 – From PCR London Valves 2022
This innovative session takes you through the patient selection and anatomical characteristics when selecting amongst the different transcatheter options to treat tricuspid regurgitation, followed by a recorded demonstration using the PASCAL Precision repair system.
Valve-in-valve interventions
27 Nov 2022 – From PCR London Valves 2022
The 8 videos in this PCR LV 2022 session on ViV procedures will allow you to learn more about ultrasound imaging for BASILICA procedure optimization in ViV TAVI, or compare coronary access between 2 self-expandable TAVI in degenerated surgical bioprosthesis, and much more!
The new PASCAL Precision system unleashes the full potential of mitral transcatheter edge-to-edge repair
28 Nov 2022 – From PCR London Valves 2022
Join this panel of experienced physicians to learn more about the novel PASCAL Precision system and to discuss implant selection and clinical data. Finally, participate in a recorded case demonstrating the use of the PASCAL Precision system for the treatment of mitral regurgitation.
iFR-SWEDEHEART: iFR vs FFR-Guided Coronary Revascularisation
04 Nov 2021
Nicola Ryan reviews the iFR Swedeheart multicenter, randomized, controlled, open-label clinical trial using the Swedish Coronary Angiography and Angioplasty Registry (SCAAR) for enrolment randomisation and follow up. At one year follow up iFR guided revascularisation was shown to be non-inferior to FFR guided revascularisation, these results...
Author
OCT insights of thrombus extraction by stent-retriever thrombectomy (SRT) and manual aspiration (MA): Insights from RETRIEVE AMI trial
29 Oct 2025
Aaysha Cader provides her take on sub-analyses of the RETRIEVE AMI trial presented by Jason Leo Walsh at TCT 2025, in San Francisco.
Author
MERIL announces successful primary outcomes of next-gen Myval THV series in major RCT, presented at EuroPCR 2024 - Earns prestigious late Breaking trial status & The LANCET acceptance.
15 May 2024
Why hypertension is a major unresolved problem
02 Oct 2024
Explore the global challenge of hypertension, affecting one in three adults, and the strategies for screening, diagnosis, and management, including lifestyle modifications, pharmacotherapy, and device-based treatments, as outlined by Sofie Brouwers.
Author
Coronary OCT and CMR imaging to determine sex differences in underlying causes of myocardial infarction with no obstructive coronary arteries
29 Mar 2026
Nicola Ryan provides her take on the trial evaluating multi-modality imaging to determine underlying causes of MINOCA in women and men. The trial results were presented by Harmony R. Reynolds at ACC.26 in New Orleans and simultaneously published in Circulation.
Author
TACSI: Dual or single antiplatelet therapy after CABG in patients with acute coronary syndrome
03 Sep 2025
Aaysha Cader provides her take on TACSI presented by Anders Jeppsson at ESC Congress 2025 in Madrid.
Author
ENVISAGE-TAVI AF: edoxaban vs. vitamin K antagonists after TAVI in patients with atrial fibrillation
31 Aug 2021
Following the Hot Line session of the ESC Congress 2021 presented by George Dangas (New-York, USA), Daniele Giacoppo offers us a condensed version of this study.
Author
